Article info

Protocol
A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol

Authors

  1. Correspondence to Julia Spierings; J.Spierings{at}umcutrecht.nl
View Full Text

Citation

Spierings J, van Rhenen A, Welsing PM, et al
A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol

Publication history

  • Received September 8, 2020
  • Revised February 15, 2021
  • Accepted February 18, 2021
  • First published March 18, 2021.
Online issue publication 
March 18, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.